GB Sciences Inc GBLX:OTCQB

RT Quote | Exchange | USD
Last | 02/26/21 EST
0.0751UNCH (UNCH)
52 week range
0.02 - 0.13

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0751
  • 52 Week High0.13
  • 52 Week High Date02/16/21
  • 52 Week Low0.02
  • 52 Week Low Date03/13/20
  • Market Cap22.04M
  • Shares Out293.52M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.29
  • 1 Year % Change114.57

RATIOS/PROFITABILITY

  • EPS (TTM)-0.04
  • P/E (TTM)-1.69
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-3.172M
  • ROE (MRQ)-421.46%
  • Revenue (MRQ)1.34M
  • Gross Margin (MRQ)-0.08%
  • Net Margin (MRQ)-916.25%
  • Debt To Equity (MRQ)-160.66%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest GB Sciences Inc News

There is no recent news for this security.

Latest GBLX News From Our Partners

QUOTE FINDER

Profile

MORE
GB Sciences, Inc., formerly Growblox Sciences, Inc., is engaged in developing and utilizing technologies in plant biology, cultivation and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a range of ailments. It intends to conduct its business operations...
John Poss
Chairman
Zach Swarts
Chief Financial Officer
Address
6450 Cameron St Ste 110A
Las Vegas, NV
89118-4337
United States